Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Medical Action Industries (NASDAQ: MDCI) shares surged 22.78 percent to close at $8.30 a share Wednesday. The stock traded between $7.15 and $8.74 on volume of 299,194 shares traded. The company reported a net income of $1.9 million for the third quarter of fiscal 2014, compared to a net loss of $55.5 million in the year ago period. Shares of Medical Action Industries are down approximately 3.0 percent year-to-date.
Get more information on Medical Action Industries and free access to the in-depth equity report at: www.FiveStarEquities.com/MDCI
Pain Therapeutics, Inc. (NASDAQ: PTIE) shares spiked 21.43 percent to close at $4.76 a share Wednesday. The stock traded between $3.85 and $4.76 on volume of 990,268 shares traded. The company reported a net profit of $31.5 million, or $0.70 per diluted share, for the full year 2013, compared to a net loss of $3.4 million, or $0.08 per share, a year prior. Shares of Pain Therapeutics are down approximately 2.0 percent year-to-date.
Get more information on Pain Therapeutics and free access to the in-depth equity report at: www.FiveStarEquities.com/PTIE
Pernix Therapeutics Holdings Inc. (NASDAQ: PTX) shares soared 68.90 percent to close at $3.53 a share Wednesday. The stock traded between $2.32 and $3.89 on volume 8.91 million shares traded. The company announced that it has attracted a $65.0 million institutional investment and has appointed Doug Drysdale as Chief Executive Officer. Shares of Pernix Therapeutics are up approximately 50.0 percent year-to-date.
Get more information on Pernix Therapeutics free access to the in-depth equity report at: www.FiveStarEquities.com/PTX
USANA Health Sciences, Inc. (NYSE: USNA) shares jumped 17.37 percent to close at $68.46 a share Wednesday. The stock traded between $64.16 and $69.98 on volume 441,830 shares traded. The company reported net sales were $186.3 million for the fourth quarter of 2013, an increase of 10.5 percent when compared to a year ago. Shares of USANA Health Sciences have are down approximately 9.0 percent year-to-date.
Get more information on USANA Health Sciences free access to the in-depth equity report at: www.FiveStarEquities.com/USNA
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]